MedPath

A study on risk factors for jaundice in newborn babies requiring readmissio

Not Applicable
Completed
Conditions
Health Condition 1: null- Intramural term and preterm babies (greater than equal to 35 weeks) who develop unconjugated hyperbilirubinemia and neonates presenting with neonatal jaundice requiring readmissionHealth Condition 2: P598- Neonatal jaundice from other specified causes
Registration Number
CTRI/2017/09/009676
Lead Sponsor
Vishal Vishnu Tewari
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
159
Inclusion Criteria

All intramural term and preterm babies greater than equal to 35 weeks gestational maturity who develop unconjugated hyperbilirubinemia and on follow-up presenting with jaundice requiring readmission.

Exclusion Criteria

a. Babies who had received intra uterine transfusion in ABO and Rh incompatibility.

b. Babies with conjugated hyperbilirubinemia

c. Age of neonate greater than 30 days

d. Gestational age below 35 weeks

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To evaluate neonates in the postnatal ward for risk factors for neonatal jaundice requiring interventionTimepoint: From the time of birth to discharge from the hospital
Secondary Outcome Measures
NameTimeMethod
a. Recognize risk factor which predispose to readmission jaundice <br/ ><br>b. Age in hours at appearance of jaundice <br/ ><br>c. Age in days for which jaundice is present. <br/ ><br>d. Duration of phototherapy given. <br/ ><br>e. Requirement of additional intervention. <br/ ><br>f. Duration of hospital stay <br/ ><br>g. Short term side effects of phototherapy <br/ ><br>Timepoint: From the time of birth upto 30 days of postnatal age
© Copyright 2025. All Rights Reserved by MedPath